you are here: HomeNewsTrendsHealth

Bangladesh detects six cases of Indian variant of coronavirus: Official

Directorate General of Health Services (DGHS) spokesman Professor Dr Nazmul Islam Munna said the cases were detected by health officials overnight. Out of the six people, two were detected in the national capital Dhaka.

May 08, 2021 / 07:21 PM IST
Representative image

Representative image

Bangladesh has detected six people, who had recently visited India, infected with the Indian variant of the COVID-19, a top health official said on Saturday.

Directorate General of Health Services (DGHS) spokesman Professor Dr Nazmul Islam Munna said the cases were detected by health officials overnight. Out of the six people, two were detected in the national capital Dhaka.

Also Read: Second or third generation versions of Indian variant may be more dangerous, says expert

All of them were exposed to the variant, also known as B.1.617, as they recently visited India and are currently kept under quarantine.

Follow our LIVE blog for latest updates of the novel coronavirus pandemic

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

"Six people have been found to be carrying the Indian variant so far and we expect more people to be detected with identical types of virus in the coming days," Munna told PTI.

"This development means we in Bangladesh need extreme caution, perfect compliance of health guidelines . . . If we maintain the guidelines, no variant -- deadly or not -- can cause major problems," Munna said.

Last month, Bangladesh sealed its borders with India due to the raging number of coronavirus cases in the neighbouring country.

But officials and reports said many people came to Bangladesh from India under special arrangements and some of them fled a mandatory quarantine, heightening risks of spreading the pandemic.

The World Health Organization (WHO) described the Indian variant as a "variant of interest," suggesting it may have mutations that would make the virus more transmissible, cause more severe disease or evade vaccine immunity.

Bangladesh reported 45 deaths in the last 24 hours, taking the total number of fatalities to 11,878. The total number of COVID-19 cases in the country stands at 772,127 with 1,285 fresh infections reported on Saturday.

Follow our full coverage of the coronavirus pandemic here.
PTI
first published: May 8, 2021 07:19 pm

stay updated

Get Daily News on your Browser
Sections